
- /
- Supported exchanges
- / DU
- / AG8.DU
AGILENT TECH - Dusseldorf Stock Exchang (AG8 DU) stock market data APIs
AGILENT TECH - Dusseldorf Stock Exchang Financial Data Overview
There is no Profile data available for AG8.DU.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get AGILENT TECH - Dusseldorf Stock Exchang data using free add-ons & libraries
Get AGILENT TECH - Dusseldorf Stock Exchang Fundamental Data
AGILENT TECH - Dusseldorf Stock Exchang Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2023-08-15
- EPS/Forecast: 1.37
Get AGILENT TECH - Dusseldorf Stock Exchang End-of-day data
EOD Historical Data package for
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
AGILENT TECH - Dusseldorf Stock Exchang News

Agilent Showcases Solutions and Partnerships Transforming Cancer Research and Therapeutics at AACR 2025
SANTA CLARA, Calif., April 24, 2025--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) announced today its participation at the American Association for Cancer Research (AACR) Annual Meeting on Apr...


With 90% institutional ownership, Agilent Technologies, Inc. (NYSE:A) is a favorite amongst the big guns
Key Insights Institutions' substantial holdings in Agilent Technologies implies that they have significant influence over the company's share price A total of 16 investors have a majority stake in th...

Reflecting On Research Tools & Consumables Stocks’ Q4 Earnings: Agilent (NYSE:A)
Reflecting On Research Tools & Consumables Stocks’ Q4 Earnings: Agilent (NYSE:A) Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s h...

Agilent Receives European IVDR Certification for Companion Diagnostic Assay in Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma
European certification for PD-L1 IHC 22C3 pharmDx to help gastric or GEJ adenocarcinoma patients for KEYTRUDA® therapy SANTA CLARA, Calif., April 17, 2025--(BUSINESS WIRE)--Agilent Technologies Inc....
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.